Biodexa Pharmaceuticals PLC (BDRX) SEC Filings — 2024
40 SEC filings for Biodexa Pharmaceuticals PLC (BDRX) in 2024.
Filings
- Biodexa Pharmaceuticals Plc Files 6-K Report — 6-K · Dec 27, 2024
- Biodexa Pharmaceuticals Plc Files December 2024 6-K Report — 6-K · Dec 4, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Nov 20, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Biodexa Pharma Complies with Nasdaq Bid Price Rule — 6-K · Nov 12, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Biodexa Pharmaceuticals Files 6-K Report — 6-K · Nov 7, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Nov 7, 2024
- Biodexa Pharmaceuticals Appoints New Auditor — 6-K · Nov 1, 2024
- Biodexa Pharmaceuticals Files 6-K Report — 6-K · Oct 15, 2024
- Biodexa Pharmaceuticals Files 6-K — 6-K · Oct 4, 2024
- Biodexa Pharmaceuticals Plc Files 6-K with Financial Data — 6-K · Sep 26, 2024
- Biodexa Pharmaceuticals Files 6-K Report — 6-K · Sep 19, 2024
- Biodexa Pharmaceuticals Files 6-K Report — 6-K · Sep 16, 2024
- Biodexa Pharmaceuticals Files Form 6-K — 6-K · Aug 30, 2024
- Biodexa Pharmaceuticals PLC SC 13G Filing — SC 13G · Aug 8, 2024
- Biodexa Sells Subsidiary for £1 — 6-K · Jul 23, 2024
- Biodexa Pharmaceuticals PLC SC 13G Filing — SC 13G · Jul 23, 2024
- Biodexa Pharmaceuticals Raises $10M in Direct Offering — 6-K · Jul 19, 2024
- Biodexa Pharmaceuticals Plc Files 6-K Report — 6-K · Jul 16, 2024
- Biodexa Pharmaceuticals PLC: CSO/CMO Departs — 6-K · Jul 5, 2024
- Biodexa Pharmaceuticals Files Form 6-K — 6-K · Jul 2, 2024
- Biodexa Pharmaceuticals Files Routine 6-K — 6-K · Jun 24, 2024
- Biodexa Pharmaceuticals PLC Files 6-K, Incorporates Exhibits — 6-K · Jun 13, 2024
- Biodexa Pharmaceuticals Files SEC Report — 6-K · May 28, 2024
- Biodexa Pharma Induces Warrant Exercise — 6-K · May 22, 2024
- Biodexa Pharmaceuticals PLC Files Form 6-K — 6-K · May 21, 2024
- Biodexa Pharmaceuticals Posts 2023 Annual Report and AGM Notice — 6-K · May 15, 2024
- Biodexa Pharmaceuticals PLC Files 6-K, Incorporates Exhibits — 6-K · May 15, 2024
- Biodexa Pharmaceuticals Files April 2024 6-K Report — 6-K · Apr 30, 2024
- Biodexa Pharmaceuticals Files Form 6-K — 6-K · Apr 26, 2024
- Biodexa Pharmaceuticals Plc Files 20-F for Fiscal Year 2023 — 20-F · Apr 19, 2024
- Biodexa Pharma Updates SEC Filings as Foreign Private Issuer — 6-K · Feb 23, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Biodexa Pharmaceuticals PLC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Bigger Capital Fund Takes 5.0% Stake in Biodexa Pharma — SC 13G · Feb 12, 2024
- Biodexa CEO Issues Shareholder Letter on 2023 Progress, 2024 Outlook — 6-K · Jan 22, 2024
- Mercer Street Global Opportunity Fund Takes 6.2% Stake in Biodexa Pharma — SC 13G · Jan 8, 2024